Mirtazapine Tablet, Film Coated
Product Images NDC 65862-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 65862-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (7.5 mg (100 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (15 mg (100 Tablet Bottle))

Package Label-principal Display Panel (15 mg (100 Tablet Bottle))
This is a description of a medication called Mirtazapine manufactured by Aurabindo Pharma USA, Inc. Each tablet of Mirtazapine contains 15 mg and must be kept in a light-resistant container at 25°C (77°F), with an allowance for temperatures between 16°C to 30°C. The prescribing information must be read before taking the medication, and a medication guide is provided separately. The medication is made in India and dispensed with a code of TSDRUGS19/1083. The remaining text is not legible.*
FDA Label Image

Package Label-principal Display Panel (30 mg (100 Tablet Bottle))

Package Label-principal Display Panel (30 mg (100 Tablet Bottle))
This is a prescription drug called Mirtazapine. The tablets contain 30mg of Mirtazapine USP. The usual dosage has to be read from the enclosed prescribing information. It should be dispensed in a tight, light-resistant container, and stored at a controlled room temperature of 25°C (77°F). The medication guide is provided separately. This drug is distributed by Aurobindo Pharma USA, Inc. and is made in India. The text includes some codes and a warning not to print the dotted lines in the printing zone.*
FDA Label Image

Package Label-principal Display Panel (45 mg (100 Tablet Bottle))

FDA Label Image

Chemical Structure (Mirtazapine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.